BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 9570477)

  • 1. Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes.
    Pradhan TK; Katsuno T; Taylor JE; Kim SH; Ryan RR; Mantey SA; Donohue PJ; Weber HC; Sainz E; Battey JF; Coy DH; Jensen RT
    Eur J Pharmacol; 1998 Feb; 343(2-3):275-87. PubMed ID: 9570477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
    Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
    J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
    Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4-R).
    Katsuno T; Pradhan TK; Ryan RR; Mantey SA; Hou W; Donohue PJ; Akeson MA; Spindel ER; Battey JF; Coy DH; Jensen RT
    Biochemistry; 1999 Jun; 38(22):7307-20. PubMed ID: 10353842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors.
    Mantey SA; Weber HC; Sainz E; Akeson M; Ryan RR; Pradhan TK; Searles RP; Spindel ER; Battey JF; Coy DH; Jensen RT
    J Biol Chem; 1997 Oct; 272(41):26062-71. PubMed ID: 9325344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3.
    Mantey SA; Coy DH; Entsuah LK; Jensen RT
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1161-70. PubMed ID: 15102928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes.
    Mantey S; Frucht H; Coy DH; Jensen RT
    Mol Pharmacol; 1993 May; 43(5):762-74. PubMed ID: 7684815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the peptide structural requirements for high affinity interaction with bombesin receptors.
    Lin JT; Coy DH; Mantey SA; Jensen RT
    Eur J Pharmacol; 1995 Dec; 294(1):55-69. PubMed ID: 8788416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromedin B receptor in esophagus: evidence for subtypes of bombesin receptors.
    Von Schrenck T; Heinz-Erian P; Moran T; Mantey SA; Gardner JD; Jensen RT
    Am J Physiol; 1989 Apr; 256(4 Pt 1):G747-58. PubMed ID: 2539739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning of a receptor for amphibian [Phe13]bombesin distinct from the receptor for gastrin-releasing peptide: identification of a fourth bombesin receptor subtype (BB4).
    Nagalla SR; Barry BJ; Creswick KC; Eden P; Taylor JT; Spindel ER
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6205-9. PubMed ID: 7597102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.
    Moreno P; Mantey SA; Nuche-Berenguer B; Reitman ML; González N; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2013 Oct; 347(1):100-16. PubMed ID: 23892571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
    Lin JT; Coy DH; Mantey SA; Jensen RT
    J Pharmacol Exp Ther; 1995 Oct; 275(1):285-95. PubMed ID: 7562561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of high affinity bombesin receptor subtype 3 agonists.
    Wu JM; Nitecki DE; Biancalana S; Feldman RI
    Mol Pharmacol; 1996 Nov; 50(5):1355-63. PubMed ID: 8913368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity requirements of bombesin for gastrin-releasing peptide- and neuromedin B-preferring bombesin receptors in rat brain.
    Guard S; Watling KJ; Howson W
    Eur J Pharmacol; 1993 Aug; 240(2-3):177-84. PubMed ID: 8243536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor.
    Gonzalez N; Hocart SJ; Portal-Nuñez S; Mantey SA; Nakagawa T; Zudaire E; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2008 Feb; 324(2):463-74. PubMed ID: 18006692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3.
    Mantey SA; Coy DH; Pradhan TK; Igarashi H; Rizo IM; Shen L; Hou W; Hocart SJ; Jensen RT
    J Biol Chem; 2001 Mar; 276(12):9219-29. PubMed ID: 11112777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand binding, internalization, degradation and regulation by guanine nucleotides of bombesin receptor subtypes: a comparative study.
    Wang LH; Mantey SA; Lin JT; Frucht H; Jensen RT
    Biochim Biophys Acta; 1993 Jan; 1175(2):232-42. PubMed ID: 8380344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: analysis of binding, kinetics, stoichiometry, modulation by guanine nucleotide-binding proteins, and signal transduction and comparison with natively expressed receptors.
    Benya RV; Wada E; Battey JF; Fathi Z; Wang LH; Mantey SA; Coy DH; Jensen RT
    Mol Pharmacol; 1992 Dec; 42(6):1058-68. PubMed ID: 1336112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells.
    Frucht H; Gazdar AF; Park JA; Oie H; Jensen RT
    Cancer Res; 1992 Mar; 52(5):1114-22. PubMed ID: 1310640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells.
    Reile H; Armatis PE; Schally AV
    Prostate; 1994 Jul; 25(1):29-38. PubMed ID: 8022709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.